Stage V Chronic Kidney Disease: A plea for Home Dialysis
DOI:
https://doi.org/10.25796/bdd.v5i3.67633Keywords:
Dialysis at home, Peritoneal dialysis, Covid-19, Dialysis out of center, Cost, DIADOM, Séminaires urologie néphrologieAbstract
Summary
Overall, home dialysis remains underutilized in much of the world. It is only in some parts of the world, such as Hong Kong, Mexico, Thailand, the Netherlands, Finland, Denmark, Iceland, Australia, Canada and New Zealand, that home dialysis is used for more than 20% of the dialysis population. It is observed that in most high- and middle-income countries, home dialysis is generally more economical than center-based dialysis.
According to the results of the REIN 2020 registry, the share of out-of-center dialysis in France has been increasing since 2012. This is mainly due to the increase in the number of patients treated in low medicalized dialysis units (LMDUs) (+7.3% per year between 2012 and 2016, then +3.8% between 2016 and 2020). In contrast, the proportion of patients treated at home has changed little. The percentage of patients on peritoneal dialysis is decreasing (-1.8% per year). Home hemodiaysis is increasing (+10.3% per year) but remains very marginal (1% of dialysis patients). Finally, the advanced age of dialysis patients, which is constantly increasing, cannot be ignored. The proportion of these very old patients has increased from 10.5% in 2012 to 12.5% in 2020. However, during the COVID-19 epidemic, several articles in the literature have demonstrated the protective effect of home dialysis in all its forms (peritoneal dialysis and home hemodialysis) against SARS-CoV-2 infection.
We report on the status of home dialysis in France, its advantages and proposals for its development, as presented at the Home Dialysis Day (DIADOM) of University Seminars of Nephrology (SUN) in Paris in January 2022.
References
2- Wang A Y-M. Comparing survival between home hemodialysis and peritoneal dialysis - is the controversy over ? Nephrol Dial Transplant 2022 Mar 15;gfac057. Doi: 10.1093/ndt/gfac057
3- Ma Maladie Rénale Chronique 2022: 10 propositions pour développer la dialyse à domicile, SFNDT (2019). https://www.sfndt.org/ sites/ www. sfndt. org/ files/ medias/ docum ents/ Livre- blanc-Dialyse-a-domicile-190528.pdf. Consulté le
4- Wilkie M. Home dialysis-an international perspective. NDT plus 2011 ; 4 (Suppl 3): iii4-iii6. Doi : 10.1093/ndtplus/sfr129
5- Baudelot C, Combe C, Tabuteau D et al : Système de santé et maladie rénale chronique: réflexions, débats et propositions. Edition de santé & Collection « Séminaires », Chaire santé de Science Po, 2018 ; ISBN 978-86411-306-05
6- Issad B, Galland R, Merle V, Lassalle M. Chapitre 1 - Prévalence de l’IRCT et part des différentes modalités de traitement. Rapport REIN 2020. Agence Biomédecine Saint-Denis la Plaine. Néphrologie et Thérapeutique 2022 ; In press
7- Li PK-T, Chan GC-K, Chen J et al. Tackling Dialysis Burden around the world : A global Challenge. Kidney Dis (Basel) 2021;7(3):167-175. Doi: 10.1159/000515541
8- SFNDT ; Rapport sur la dialyse chronique en France en 2016 ; Néphrologie et Thérapeutique 2017 ;13(2) :105-126. https://doi.org/10.1016/j.nephro.2016.06.008
9- Issad B, Jacobs C, Rostoker G. Quinze pour cent de patients dialysés traités par DPCA/DPA en 2010 : mythe ou réalité ? Néphrologie et Thérapeutique 2006;2(6):363-365. doi : 10.1016/jnephro.2006.07.011
10- Bordet M (2020) Le boulot sans le métro: enquête sur une révolution. J Le Point. https://www.lepoint.fr/economie/le-boulot-sans-le-metro-20-05-2020-2376299_28.php#xtmc=le-boulot-sans-le-metro-enquete-sur-une-revolution&xtnp=1&xtcr=1. Consulté le 28/07/2022
11- Collectif (2020) Manifeste pour une révolution de la longévité. Le Monde, Tribune du 27 mai 2020:31. https://www.uniopss.asso.fr/sites/default/files/fichiers/uniopss/tribune_lemonde_manifeste_pour_une_revolution_de_la_longevite_27.05.pdf. Consulté le 28/07/2022
12- Pierratos A, Tremblay M, Kandasamy G et al. Personal Support Worker (PSW)-supported home hemodialysis: A paradigm shift. Hemodial Int 2017;21(2):173-179. Doi: 10.1111/hdi.12476
13- Haute Autorité de Santé (2015). Expérimentation des parcours de soins des patients atteints de MRC- Dispositif d’annonce d’insuffisance rénale avancée et de décision partagée sur le mode de suppléance. Décision n°2015.0112/DC/SMACDAM du 6 mai 2015. Saint Denis la Plaine. https://www.has-sante.fr/upload/docs/application/pdf/2015-10/dispositif_annonce_suppleance_web.pdf; https://www.has-sante.fr/upload/docs/application/pdf/2015-10/c_2015_0112_dispositif_annonce_suppleance.pdf
14- Nouvier M, Verger C, Fouque D. Situation de l’épidémie de Covid-19 chez les patients en dialyse péritonéale au 15/05/2020 en France : Bases de données du RDPLF. Bulletin de la Dialyse à Domicile (BDD).2020 ;3(2) :73-81. https://doi.org/10.25796/bdd.v3i2.55433
15- Rostoker G, Issad B, Fessi H, Massy ZA. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective. J of Nephrol 2021;34(4),985-989. Doi: 10.1007/s40620-021-01061-7
16- Rostoker G, Issad B, Fessi H, Massy Z. Favoriser le traitement à domicile des patients dialysés à l’heure de la pandémie de la Covid-19. Tribune Sciences - Médecine Le Monde. 11/03/2021. https://www.lemonde.fr/sciences/article/2021/03/11/favoriser-le-traitement-a-domicile-des-patients-dialyses-a-l-heure-de-la-pandemie-du-covid-19_6072701_1650684.html. Consulté le 28/07/2022
17- Michel PA, Piccoli GB, Couchoud C et al. Home hemodialysis during the COVID-19 epidemic: Comment on the French experience from the viewpoint of a French home hemodialysis care network. J Nephrol 2020;33(6):1125- 1127. Doi : 10.1007/s40620-020-00893-z
18- Manganaro M, Baldovino S, on behalf of the working group of the Piedmont and Aosta Valley section of the SIN. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol 2020;33(3):393-395. Doi: 10.1007/s40620-020-00732-1
19- Brown EA, Perl P. Increasing peritoneal dialysis use in response to the COVID-19 pandemic: Will it go Viral? J Am Soc Nephrol 2020;31(9):1928-1930. Doi: 10.1681/ASN.2020050729
20- Site de la société de néphrologie Italienne (Societa Italiana Nefro-logia – Coronavirus and Dialisi). https://sinitaly.org/coronavirus/. Consulté le
21- Kissler SM, Tedijanto C, Goldstein E et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020; 368(6493):860-868. doi : 10.1126/science.abb5793
22- Pert J, Bieber B, Tu C et al. The DOPPS Practice Monitor-Peritoneal Dialysis (DPM-PD): From Practice to Policy and Policy to Practice. Am J Kidney Dis 2022. Doi: https://doi.org/10.1053/j.ajkd.2022.03.005. In press
23- Issad B : Place de la dialyse péritonéale dans le monde et en France : aspects épidémiologiques et principales indications. Bulletin de l’Académie de Nationale de médecine 2022; 206(2) :200-214. https://doi.org/10.1016/j.banm.2021.12.003
24- Académie Nationale de médecine. La dialyse péritonéale : un traitement à développer pour la prise en charge de l’insuffisance rénale chronique terminale. Communiqué de la Cellule de Communication Rapide de l’Académie validé par les membres du Conseil
d’administration le 14 mars 2022. https://www.academie-medecine.fr/wp-content/uploads/2022/03/22.3.14-La-dialyse-peritoneale-PCRA-21.pdf. Consulté le 28/07/2022
25- Association RENALOO - La voix des malades du rein. Information et décision partagée : les principaux résultats de notre enquête auprès des patients dialysés et greffés. Février 2016. https://renaloo.com/information-et-decision-partagee-les-resultats-preliminaires-de-notre-enquete-aupres-des-patients-dialyses-et-greffes/ Consulté le 28/07/2022
26- Bechu T. Note interne de la Fédération des Cliniques et Hôpitaux Privés branche Médecine, Chirurgie et Obstétrique (FHP MCO) sur l’évolution des financements de la dialyse durant les années 2014-2021
27- Chan L, Chaudhary K, Saha A et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol 2021;32(1):151-160. doi: 10.1681/ASN.2020050615
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Belkacem Issad
This work is licensed under a Creative Commons Attribution 4.0 International License.